NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Ce...(ke (VSEL) stem cell technology. VSELs ha...)

Date:10/27/2008

ke (VSEL) stem cell technology." VSELs have been identified in adult bone marrow and resemble embryonic stem cells both morphologically and transcriptionally. NeoStem's new Boston area facility will focus on quantifying VSEL mobilization and establishing laboratory conditions for their expansion. These research efforts will be aimed at directing VSEL differentiation into various progenitor populations with the goal of developing adult stem cell therapies.

"NeoStem continues to achieve important strategic milestones during this very exciting period of its expansion and growth. We are proud to have them as a partner," said John Rizza, CEO of New England Cryogenic Center, Inc.

The securities sold in the private placement were sold without registration under the Securities Act of 1933, as amended (the "Act") and may not be resold unless subsequently registered under the Act or pursuant to an exemption from registration under the Act.

About NeoStem, Inc.

NeoStem is developing a network of adult stem cell collection centers that are focused on enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times for future medical need. The Company has also recently entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.

For more information, please visit: http://www.neostem.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertain
'/>"/>

SOURCE NeoStem, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
2. NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
3. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
4. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
5. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
6. NeoStem to Expand Stem Cell Collection Center Network to Florida
7. NeoStem Featured in WCBS-TV Health Watch Segment on Adult Stem Cells
8. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
9. NeoStem to Present at Third Annual Stem Cell Summit in New York City
10. NeoStem Announces NY State License for Adult Stem Cell Collection
11. Transave, Inc. Secures $12.5 Million in New Financing